TXMD TherapeuticsMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TXMD

Price (delayed)

$1.86

Market cap

$21.45M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.98

Enterprise value

$23.66M

TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women ...

Highlights
TXMD's quick ratio is up by 21% since the previous quarter and by 2.9% year-on-year
TXMD's debt is down by 11% year-on-year and by 3.1% since the previous quarter
The equity has contracted by 17% YoY but it has grown by 4.4% from the previous quarter
The net income has plunged by 115% from the previous quarter and by 109% YoY
The company's EPS has shrunk by 113% QoQ and by 108% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.therapeuticsmd.com
Peers: ABBV PFE RPRX

Key stats

What are the main financial stats of TXMD
Market
Shares outstanding
11.53M
Market cap
$21.45M
Enterprise value
$23.66M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
14.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.17
Earnings
Revenue
$1.3M
EBIT
-$10.32M
EBITDA
-$9.4M
Free cash flow
-$48.14M
Per share
EPS
-$0.98
Free cash flow per share
-$4.61
Book value per share
$2.77
Revenue per share
$0.12
TBVPS
$3.56
Balance sheet
Total assets
$43.31M
Total liabilities
$14.02M
Debt
$6.53M
Equity
$29.29M
Working capital
$4.94M
Liquidity
Debt to equity
0.22
Current ratio
1.72
Quick ratio
1.08
Net debt/EBITDA
-0.23
Margins
EBITDA margin
-721.9%
Gross margin
100%
Net margin
-789.4%
Operating margin
-654.6%
Efficiency
Return on assets
-19.9%
Return on equity
-34.1%
Return on invested capital
-38.4%
Return on capital employed
-28.3%
Return on sales
-792.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TXMD stock price

How has the TherapeuticsMD stock price performed over time
Intraday
-2.11%
1 week
-6.53%
1 month
-18.78%
1 year
-49.59%
YTD
-17.33%
QTD
-18.78%

Financial performance

How have TherapeuticsMD's revenue and profit performed over time
Revenue
$1.3M
Gross profit
$1.3M
Operating income
-$8.52M
Net income
-$10.28M
Gross margin
100%
Net margin
-789.4%
TherapeuticsMD's operating income has shrunk by 121% QoQ
The net income has plunged by 115% from the previous quarter and by 109% YoY
TXMD's revenue has dropped by 98% year-on-year and by 98% since the previous quarter
The gross profit has plunged by 98% from the previous quarter and by 98% YoY

Growth

What is TherapeuticsMD's growth rate over time

Valuation

What is TherapeuticsMD stock price valuation
P/E
N/A
P/B
0.67
P/S
14.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.17
The company's EPS has shrunk by 113% QoQ and by 108% YoY
The stock's price to book (P/B) is 39% less than its last 4 quarters average of 1.1
The equity has contracted by 17% YoY but it has grown by 4.4% from the previous quarter
TXMD's revenue has dropped by 98% year-on-year and by 98% since the previous quarter
TXMD's price to sales (P/S) is 31% higher than its 5-year quarterly average of 11.4

Efficiency

How efficient is TherapeuticsMD business performance
TXMD's return on assets has dropped by 122% year-on-year and by 119% since the previous quarter
TherapeuticsMD's ROE has plunged by 116% from the previous quarter
The ROIC has plunged by 110% from the previous quarter

Dividends

What is TXMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TXMD.

Financial health

How did TherapeuticsMD financials performed over time
TXMD's total liabilities has dropped by 75% year-on-year and by 38% since the previous quarter
TXMD's total assets has dropped by 52% year-on-year and by 14% since the previous quarter
TXMD's debt is 78% smaller than its equity
The equity has contracted by 17% YoY but it has grown by 4.4% from the previous quarter
TXMD's debt is down by 11% year-on-year and by 3.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.